Related Experiment Video

Updated: Jun 6, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1)

Wei Li1, Filippo G Giancotti

  • 1Sloan-Kettering Institute for Cancer Research, New York, NY, USA.

Cell Cycle (Georgetown, Tex.)
|November 19, 2010
PubMed

Insights

The tumor suppressor Merlin restrains cell proliferation by inhibiting the E3 ubiquitin ligase CRL4 (DCAF1) in the nucleus. Loss of Merlin unleashes CRL4 (DCAF1) activity, driving cancer and hyperproliferation.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Genetics

Background:

  • The tumor suppressor gene NF2 encodes the FERM domain protein Merlin, crucial for restraining cell proliferation.
  • Merlin's antimitogenic mechanism, particularly its nuclear functions, remains incompletely understood.
  • Previous research suggested Merlin's interactions with plasma membrane proteins mediate its tumor-suppressive effects.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Merlin restrains cell proliferation.
  • To investigate Merlin's nuclear functions and its interaction with CRL4 (DCAF1).
  • To explore the therapeutic potential of targeting CRL4 (DCAF1) in Merlin-deficient cancers.

Main Methods:

  • Nuclear translocation assays to track Merlin localization.
  • Co-immunoprecipitation to study Merlin-CRL4 (DCAF1) interactions.
  • Genetic manipulation (e.g., gene inactivation) to assess the impact on cell proliferation and gene expression.
  • In vivo tumorigenicity assays.

Main Results:

  • Merlin translocates into the nucleus and directly binds to and inhibits the E3 ubiquitin ligase CRL4 (DCAF1).
  • Inactivation of Merlin leads to the unleashing of CRL4 (DCAF1) activity.
  • Loss of Merlin induces oncogenic gene expression, hyperproliferation, and promotes tumorigenicity.
  • Genetic evidence links Merlin inactivation to CRL4 (DCAF1) hyperactivity.

Conclusions:

  • Merlin acts as a nuclear inhibitor of CRL4 (DCAF1), explaining its tumor-suppressive role.
  • The Merlin-CRL4 (DCAF1) axis is a critical regulator of cell proliferation and oncogenesis.
  • Inhibitors of CRL4 (DCAF1) represent a promising therapeutic strategy for Neurofibromatosis type 2 and other Merlin-inactivated cancers.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...